Atika Capital Management LLC Zai Lab LTD Transaction History

Atika Capital Management LLC

$874 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$22.72 - $31.49 $2.57 Million - $3.56 Million	-113,000 Reduced 77.93%	32,000 $777,000
Q2 2023 Aug 11, 2023	SELL	$25.3 - $39.67 $366,850 - $575,215	-14,500 Reduced 9.09%	145,000 $4.02 Million
Q1 2023 May 12, 2023	SELL	$30.21 - $48.1 $2.36 Million - $3.76 Million	-78,156 Reduced 32.89%	159,500 $5.3 Million
Q4 2022 Feb 13, 2023	SELL	$22.28 - $38.71 $2.5 Million - $4.35 Million	-112,344 Reduced 32.1%	237,656 $7.3 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $3.83 Million - $5.79 Million	112,000 Added 47.06%	350,000 $12 Million
Q2 2022 Aug 12, 2022	BUY	$23.14 - $49.68 $69,420 - $149,040	3,000 Added 1.28%	238,000 $8.25 Million
Q1 2022 May 13, 2022	SELL	$27.77 - $64.4 $1.06 Million - $2.45 Million	-38,000 Reduced 13.92%	235,000 $10.3 Million
Q4 2021 Feb 11, 2022	SELL	$54.9 - $105.21 $774,090 - $1.48 Million	-14,100 Reduced 4.91%	273,000 $17.2 Million
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $220,500 - $374,577	2,100 Added 0.74%	287,100 $30.3 Million
Q2 2021 Aug 12, 2021	BUY	$125.11 - $180.0 $2.5 Million - $3.6 Million	20,000 Added 7.55%	285,000 $50.4 Million
Q1 2021 May 14, 2021	SELL	$126.27 - $191.71 $8.21 Million - $12.5 Million	-65,000 Reduced 19.7%	265,000 $35.4 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $3.77 Million - $6.23 Million	46,000 Added 16.2%	330,000 $44.7 Million
Q3 2020 Nov 13, 2020	SELL	$73.3 - $89.48 $146,600 - $178,960	-2,000 Reduced 0.7%	284,000 $23.6 Million
Q2 2020 Aug 13, 2020	SELL	$48.82 - $82.53 $2.15 Million - $3.63 Million	-44,000 Reduced 13.33%	286,000 $23.5 Million
Q1 2020 May 14, 2020	BUY	$39.1 - $62.9 $1.76 Million - $2.83 Million	45,000 Added 15.79%	330,000 $17 Million
Q4 2019 Feb 14, 2020	SELL	$29.79 - $43.06 $592,821 - $856,894	-19,900 Reduced 6.53%	285,000 $11.9 Million
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $1.83 Million - $2.26 Million	59,900 Added 24.45%	304,900 $9.86 Million
Q2 2019 Aug 12, 2019	BUY	$25.73 - $35.79 $1.8 Million - $2.51 Million	70,000 Added 40.0%	245,000 $8.54 Million
Q1 2019 May 13, 2019	BUY	$21.71 - $31.54 $1.39 Million - $2.02 Million	64,000 Added 57.66%	175,000 $5.17 Million
Q4 2018 Feb 14, 2019	BUY	$14.95 - $24.72 $1.66 Million - $2.74 Million	111,000 New	111,000 $2.58 Million

Others Institutions Holding ZLAB

# of Institutions

124

Shares Held

48.5M

Call Options Held

223K

Put Options Held

588K

Janus Henderson Group PLC London, X0

8.76M
Shares

$238 Million
0.11% of portfolio
Wellington Management Group LLP Boston, MA

8.44M
Shares

$229 Million
0.04% of portfolio
Capital World Investors Los Angeles, CA

6.44M
Shares

$175 Million
0.02% of portfolio
Viking Global Investors LP

1.95M
Shares

$53 Million
0.18% of portfolio
Bamco Inc New York, NY

1.91M
Shares

$51.8 Million
0.13% of portfolio

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.66B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Account